Elliot Norry, Chief Medical Officer at Adaptimmune Therapeutics PLC (ADAP), sold 2,159 shares at $1.86 ($4K) on 2023-01-17, disclosed to the SEC on 2023-01-17.
Seasonal sale ($4k) by Chief Medical Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ADAP | SELL | 2024-01-17 | $14K | — | Filing → |
| ADAP | SELL | 2024-01-12 | $10K | — | Filing → |
| ADAP | SELL | 2023-01-12 | $19K | — | Filing → |